Research Article
[Retracted] Diagnostic Value of FTO Combined with CEA or CYFRA21-1 in Nonsmall Cell Lung Cancer
Table 2
Association of CEA with clinical data of NSCLC patients (n, %).
| Index | Relative expression of CEA | value | High expression (n = 30) | Low expression (n = 30) |
| Age | ≥60 years (n = 33) | 15 | 18 | 0.436 | <60 years (n = 27) | 15 | 12 | Gender | Male (n = 35) | 16 | 19 | 0.432 | Female (n = 25) | 14 | 11 | Tumour size | ≥3 cm (n = 30) | 18 | 12 | 0.121 | <3 cm (n = 30) | 12 | 18 | Clinical staging | I + II (n = 37) | 14 | 23 | | III + IV (n = 23) | 16 | 7 | Lymph node metastasis | Yes (n = 18) | 10 | 8 | 0.573 | None (n = 42) | 20 | 22 | Tumour type | Squamous cell carcinoma (n = 27) | 8 | 19 | | Adenocarcinoma (n = 33) | 22 | 11 |
|
|
Note. denotes a notable difference. |